HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections.

AuthorsMohd H Abdul-Aziz, Jeffrey Lipman, Jason A Roberts
JournalCritical care (London, England) (Crit Care) Vol. 21 Issue 1 Pg. 283 (11 21 2017) ISSN: 1466-609X [Electronic] England
PMID29157264 (Publication Type: Editorial)
Chemical References
  • Anti-Bacterial Agents
  • beta-Lactams
Topics
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Critical Illness (therapy)
  • Dose-Response Relationship, Drug
  • Humans
  • Infections (drug therapy, mortality)
  • Intensive Care Units (organization & administration)
  • beta-Lactams (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: